Effects of hyperbaric oxygen exposure on a zymosan-induced shock model

被引:72
作者
Luongo, C
Imperatore, F
Cuzzocrea, S
Filippelli, A
Scafuro, MA
Mangoni, G
Portolano, F
Rossi, F
机构
[1] Univ Naples 2, Fac Med, Inst Pharmacol & Toxicol, Inst Analgesia Anaesthesia Rianimat & Hyperbar Me, I-80138 Naples, Italy
[2] Univ Messina, Inst Pharmacol, Messina, Italy
[3] UNICAL, Pharmacobiol Dept, Cosenza, Italy
关键词
zymosan; shock; nitric oxide; hyperbaric oxygen therapy; peritonitis; tumor necrosis factor-alpha;
D O I
10.1097/00003246-199812000-00022
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the effects of hyperbaric oxygen (HBO) therapy on zymosan induced shock in rats. Zymosan, a cell wall component of the yeast Saccharomyces cerevisiae, induces inflammation by causing the production of various cytokines and pro-inflammatory mediators. The administration of zymosan to rats represents a new experimental shock model by inducing acute peritonitis, severe hypotension, and signs of systemic illness. However, it has been recently proposed that the zymosan induced shock, like septic shock, may be mediated by overproduction of nitric oxide. Design: Experimental study. Setting: Institute of Pharmacology and Toxicology, 2(nd) University of Naples, Naples, Italy. Subjects: Male rats were treated with zymosan (500 mg/kg) by intraperitoneal route, with HBO (2 Absolute Atmosphere) or with zymosan and HBO (2 Absolute Atmosphere). Measurements and Main Results: Peritoneal exudate, plasma, and peritoneal nitric oxide metabolites (NOx) and zymosan determined a time dependent increase in peritoneal and plasma NOx concentrations, and peritoneal leukocytes were determined. More over, symptomatology was observed. The administration of zymosan caused the appearance of a severe illness in the rats characterized by ruffled fur, lethargy, conjunctivitis, diarrhea, and a significant loss of body weight. All zymosan-treated rats developed an acute peritonitis, producing turbid exudate. Zymosan determined a time dependent increase in peritoneal, plasma NOx, and tumor necrosis factor (TNF)-alpha concentrations. Morbidity of zymosan shocked rats has been attenuated and no mortality was observed by treatment with HBO. These findings were associated with a significant reduction either of peritoneal leukocytes and exudate, or plasma and peritoneal NOx concentrations. Moreover, TNF a levels were significantly reduced in animals shocked by zymosan and treated with HBO. Conclusions: Our findings suggest that HBO may also be an efficacious treatment in zymosan-induced experimental shock model.
引用
收藏
页码:1972 / 1976
页数:5
相关论文
共 18 条
  • [1] Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat
    Cuzzocrea, S
    Filippelli, A
    Zingarelli, B
    Falciani, M
    Caputi, AP
    Rossi, F
    [J]. SHOCK, 1997, 7 (05): : 351 - 357
  • [2] PLATELET-ACTIVATING-FACTOR AND THE VASCULAR EFFECTS OF ZYMOSAN IN RATS
    DAMAS, J
    REMACLEVOLON, G
    BOURDON, V
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) : 231 - 236
  • [3] COMPARISON BETWEEN LUNG AND LIVER LIPID-PEROXIDATION AND MORTALITY AFTER ZYMOSAN PERITONITIS IN THE RAT
    DEMLING, R
    NAYAK, U
    IKEGAMI, K
    LALONDE, C
    [J]. SHOCK, 1994, 2 (03): : 222 - 227
  • [4] EACHTENACHER B, 1995, J INFLAMM, V47, P85
  • [5] IZAWA K, 1993, GASTROENTEROL JPN, V28, P284
  • [6] Lahat N, 1995, CLIN EXP IMMUNOL, V102, P655
  • [7] MAINOUS MR, 1991, ARCH SURG-CHICAGO, V126, P33
  • [8] HYPERBARIC-OXYGEN AFTER GLOBAL CEREBRAL-ISCHEMIA IN RABBITS REDUCES BRAIN VASCULAR-PERMEABILITY AND BLOOD-FLOW
    MINK, RB
    DUTKA, AJ
    [J]. STROKE, 1995, 26 (12) : 2307 - 2312
  • [9] MONCADA S, 1993, NEW ENGL J MED, V329, P2002
  • [10] Pelaia P, 1995, Minerva Anestesiol, V61, P133